Search research articles
Contact Us
Filters
Showing results (271-280 of 329) with videos related to
Page
of 33
Sort By:
Oncotarget
|
December 1, 2016
Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer
Alireza Fotouhi Ghiam, Samira Taeb, Xiaoyong Huang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 study
Emmanouil Fokas, Lena Conradi, Christian Weiss, et al.
BMC Cancer
|
September 14, 2016
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol
Daniel L P Holyoake, Elizabeth Ward, Derek Grose, et al.
Cell Death & Disease
|
December 11, 2012
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
E Fokas, R Prevo, J R Pollard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 29, 2017
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease
Athanasios D Spathis, Xenophon Asvos, Despina Ziavra, et al.
Cancer Research
|
August 3, 2017
Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
Zenobia D'Costa, Keaton Jones, Abul Azad, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
March 12, 2015
X-ray, spectroscopic and normal-mode dynamics of calexcitin: structure-function studies of a neuronal calcium-signalling protein
P T Erskine, A Fokas, C Muriithi, et al.
ESMO Open
|
September 11, 2024
mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)
R-D Hofheinz, F Herrle, T Dechow, et al.
The Lancet. Oncology
|
May 4, 2020
Outcome measures in multimodal rectal cancer trials
Emmanouil Fokas, Robert Glynne-Jones, Ane Appelt, et al.
Nature Reviews. Gastroenterology & Hepatology
|
March 15, 2024
Future direction of total neoadjuvant therapy for locally advanced rectal cancer
Yoshinori Kagawa, J Joshua Smith, Emmanouil Fokas, et al.
Page
of 33
Search research articles
Search
Showing results (271-280 of 329) with videos related to
Sort By:
Page
of 33
Oncotarget
|
December 1, 2016
Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer
Alireza Fotouhi Ghiam, Samira Taeb, Xiaoyong Huang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 study
Emmanouil Fokas, Lena Conradi, Christian Weiss, et al.
BMC Cancer
|
September 14, 2016
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol
Daniel L P Holyoake, Elizabeth Ward, Derek Grose, et al.
Cell Death & Disease
|
December 11, 2012
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
E Fokas, R Prevo, J R Pollard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 29, 2017
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease
Athanasios D Spathis, Xenophon Asvos, Despina Ziavra, et al.
Cancer Research
|
August 3, 2017
Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
Zenobia D'Costa, Keaton Jones, Abul Azad, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
March 12, 2015
X-ray, spectroscopic and normal-mode dynamics of calexcitin: structure-function studies of a neuronal calcium-signalling protein
P T Erskine, A Fokas, C Muriithi, et al.
ESMO Open
|
September 11, 2024
mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)
R-D Hofheinz, F Herrle, T Dechow, et al.
The Lancet. Oncology
|
May 4, 2020
Outcome measures in multimodal rectal cancer trials
Emmanouil Fokas, Robert Glynne-Jones, Ane Appelt, et al.
Nature Reviews. Gastroenterology & Hepatology
|
March 15, 2024
Future direction of total neoadjuvant therapy for locally advanced rectal cancer
Yoshinori Kagawa, J Joshua Smith, Emmanouil Fokas, et al.
Page
of 33